Equipment Flashcards
Outline Principle of Cardiopulmonary Excercise Testing
Evaluate role of CPET in a patient undergoing an oesphagectomy
CPET is a non-invasive dynamic test of the cardiopulmonary system
Aims to determine a patients functional capacity
Measures anaerobic thershold, peak O2 consumptions, ventilatory efficiency for CO2
Reduction in these variables is associated with worse post op outcomes
Namely mortality, morbidity , increased hospital and ICU stay
Test uses a electromagnetically braked cycle ergometre
Takes around 10 mins
Predifined program using patients age, weight, height and gender
Measures expired gases, ECG, NIBP, HR, SpO2
Data is entered into nine plot panel to give AT, Vo2 peak and Ve/Vco2
B
USEFUL to risk stratify patients particulary as oesphagectomy is a high risk procedure and post operative complications are increased
Results made help guide MDT decision making eg: proceed to surgery, consider alternatives or prehabilitation (evidence lacking) also for post operative disposition eg ICU/HDU
What are the complications associated with residual neuromuscular blockade (30)
Evaluate the methods availiable to assess for residual NMB
INCREASED POSTOPERATIVE PULMONARY COMPLICATIONS
eg hypoxia, aspiration as decreased airway reflexes, poor cough atelectasis
POOR patient experience - phycological distress
Potenial for re-intubation
Increased time in PACU
B)
Methods include clinical judgement, Quantitative and Qualitative Neuromuscular monitoring
Evidence has shown that TOFR >0.9 to be adaquately reversed and minimise risk of PPC
Clinical eg head lift, hand grip is not uselful in determining residual NMB. Studies shown 50% patients have residual blockade
QUALITATIVE - visual or tactile feedback
includes TOF/DBS/PTC
TOF + visual/tactil unable to detect fade TOFR >0.4
DBS + visual/tactile unable to detect fade TOFR >0.6
PTC - used for deep blockage - not appropriate
None of these methods are able to determine TOFR >0.9 so are not useful clinically.
Quatitative with accelomyography eg STIMPOD
most accurate clinical device to objectively determine residual blockade
Main issues - some types require calibration PRIOR to initial NMBD so needs to be placed on for whole case and calibration
Need access to arm, and applied appropraitely,
Classify possible causes of awareness under general anaesthesia 70%
Evaluate Evidence for BIS in reducing awareness 30%
Patient
- inadequate drug dose - morbid obesity , tolerance 2nd ETOH, Benzodiazepines
- unable to deliver sufficient dose - unstable patient significant blood loss, trauma, GA emLSCS
Anaesthesia
- human error - wrong dose, unfamiliar drug STP in GA LSCS, NDMB when patient not unconscious or failing to reverse, difficult airway - not delivering anaesthetic - no TIVA, experience , out of hours, fatigue
Equipment, cannnula failure, pump failure, error in monitoring , (failure of titration?)
Awareness is RARE
Cochrane review found that BIS vs clinical signs there was low certaintly that BIS reduced awareness in a general surgical population (B-aware)
In high risk populations BIS (40-60) has been compared to volatile MAC 0.7-1.3 and found no difference in awareness outcomes
Overall, I think BIS is a useful tool if running TIVA using NMBD as although awareness is rare (1:8600 with NDMB) it is a devestating complication
USEFUL TOOL WITH fastidious patient monitoring and preparation